Walgreen Shareholders Approve Remaining Alliance Boots Stake Purchase

Mukesh Buch
29 Dec, 2014
New York City

AMAG Pharma and Takeda Pharma terminate March 2010 license. FLIR Systems secured $27 million contract from the Department of Defense. Manitowoc surged after Carl Icahn acquired 7.77% stake. Walgreen investor voted for remaining stake of Alliance Boots.

[R]1:50 PM New York – AMAG Pharma and Takeda Pharma terminate March 2010 license. FLIR Systems secured $27 million contract from the Department of Defense. Manitowoc surged after Carl Icahn acquired 7.77% stake. Walgreen investor voted for remaining stake of Alliance Boots.[/R]

Tollbooth Strategy Index rose 0.2% or 24.20 to 10,183.81.

Earnings Review

AMAG Pharmaceuticals, Inc ((AMAG)) halted at $42.68 after the specialty pharmaceutical company and Japan-based Takeda Pharmaceutical Company Limited announced today that they have agreed to mutually terminate the March 2010 license.

FLIR Systems, Inc fell 10 cents to $33.22 after the thermal imaging system designer received first full-rate production orders for a five-year duration from the U.S. Department of Defense for $27.1 million.

Kratos Defense & Security Solutions, Inc ((KTOS)) rose 2 cents to $5.10 after the national security service provider secured contract worth $9 million for electronic warfare, missile and radar system program.

Manitowoc Company Inc ((MTW)) surged 8.6% or $1.81 to $22.74 after activist investor Carl Icahn disclosed a 7.77% stake in the engineered lifting equipment provider.

Walgreen Company ((WAG)) rose 15 cents to $76.61 after the retail drugstore chain’s shareholders voted to acquire remaining 55% stake of European rival Alliance Boots GmbH that it does not currently own for $4.9 billion plus shares.

Walgreen Boots Alliance will be listed on the Nasdaq stock exchange and will trade under the ticker symbol “WBA.”

The company expects to complete the acquisition by December 31.